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ABSTRACT
Background Under the Family Smoking Prevention
and Tobacco Control Act (FSPTCA), the Food and Drug
Administration (FDA) banned the use of “Lights”
descriptors or similar terms on tobacco products that
convey messages of reduced risk. Manufacturers
eliminated terms explicitly stated and substituted colour
name descriptors corresponding to the banned terms.
This paper examines whether the tobacco industry
complied with or circumvented the law and potential
FDA regulatory actions.
Methods Philip Morris retailer manuals, manufacturers’
annual reports ﬁled with the Massachusetts Department
of Public Health, a national public opinion survey, and
market-wide cigarette sales data were examined.
Results Manufacturers substituted “Gold” for “Light”
and “Silver” for “Ultra-light” in the names of Marlboro
sub-brands, and “Blue”, “Gold”, and “Silver” for
banned descriptors in sub-brand names. Percent ﬁlter
ventilation levels, used to generate the smoke yield
ranges associated with “Lights” categories, appear to
have been reassigned to the new colour brand name
descriptors. Following the ban, 92% of smokers reported
they could easily identify their usual brands, and 68%
correctly named the package colour associated with their
usual brand, while sales for “Lights” cigarettes remained
unchanged.
Conclusions Tobacco manufacturers appear to have
evaded a critical element of the FSPTCA, the ban on
misleading descriptors that convey reduced health risk
messages. The FPSTCA provides regulatory mechanisms,
including banning these products as adulterated (Section
902). Manufacturers could then apply for pre-market
approval as new products and produce evidence for FDA
evaluation and determination whether or not sales of
these products are in the public health interest.
INTRODUCTION
The Food and Drug Administration (FDA) regulates
industries accounting for nearly 25% of consumer
spending in the USA for protection of the nation’s
public health and safety.1 On 23 June 2009, the US
President signed into law the Family Smoking
Prevention and Tobacco Control Act (FSPTCA, the
Act) extending the FDA authority to tobacco pro-
ducts, which take the lives of over 400 000
Americans each year.2 The FSPTCA vests the FDA
with the authority to set standards for tobacco pro-
ducts and the power as gatekeeper to control the
entry of new products into the market, while pro-
ducts that were on the market prior to the Act’s
passage were allowed to remain. The signiﬁcance of
the FDA’s new role is comparable with its authority
over pharmaceuticals, which according to Professor
Daniel Carpenter, member of the Institute of
Medicine advisory panel to the FDA, allows it ‘to
check and constrain a very large and politically
dominant industrial sector’.3 Premarket approval is
required for any tobacco product introduced after
15 February 2007 that is not deemed by the FDA
to have substantial equivalence to a predicate
product on the market as of that date. Importantly,
Section 900 of the Act deﬁnes a brand as ‘a variety
of tobacco product distinguished by the tobacco
used, tar content, nicotine content, ﬂavoring used,
size, ﬁltration, packaging, logo, registered trade-
mark, brand name, identiﬁable pattern of colors, or
any combination of such attributes,’, which allows
the FDA to regulate the label and brand name as
part of the tobacco product.2
This article examines the industry response to
Section 911(b)(2)(ii) of the law, which came into
effect on 22 June 2010, banning the use of explicit
or implicit descriptors that convey messages of
reduced risk including ‘light’, ‘mild’ and ‘low’, or
similar descriptions in a tobacco product, label,
labelling or advertising unless the manufacturer
demonstrates to the FDA that the product signiﬁ-
cantly reduces harm and the risk of tobacco-related
disease to individual tobacco users and beneﬁts the
health of the population as a whole.3 This action
was based on ﬁndings, including a 2006 US federal
court decision that the major US cigarette manufac-
turers were guilty under the Racketeer-Inﬂuenced
and Corrupt Organization Act (RICO), citing ‘long-
standing and continuing fraudulent efforts to
deceive the American public about ‘light’ and ‘low
tar’ cigarettes’, marketing them as less harmful
when manufacturers knew they were not.’4 Judge
Gladys Kessler ruled, ‘Consumers’ false belief [of
Lights] is so pervasive and longstanding and has
been exploited and promoted by Defendants
[tobacco manufacturers] for so long, that prevent-
ing and restraining Defendants’ future fraud
requires a ban on any future use of descriptors
which convey a health message.’4
Marketing of ‘Light’ cigarettes, a term used in
this paper to include ‘light’ ‘mild’, ‘medium’, ‘low’,
‘1owest’ and ‘ultralight’ cigarettes, surged after the
ﬁrst U.S. Surgeon General’s 1964 report which
found that cigarette smoking causes disease.5
During that time, tobacco manufacturers intro-
duced ﬁlter ventilation, small holes placed before
the machine attachment to lower tar and nicotine
yields of cigarettes, using a standardised method
developed by the Federal Trade Commission.
Manufacturers used these measures to describe
brands as light based on low yields and to convey
messages of reduced risk despite the fact that the
Federal Trade Commission method was neither
intended nor able to predict actual human exposure
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to toxins. According to Philip Morris (PM), ﬁlter ventilation
allows the mixing of air with smoke at controlled ratios and was
used to classify cigarettes with ‘Lights’ and full-ﬂavour categor-
ies: 0%–10% ventilation ‘full ﬂavour’, 20%–30% ventilation
‘light’, 45%–70% ventilation ‘ultra-light’ and 60%–75% ventila-
tion ‘lowest’.6
The 2001 National Cancer Institute (NCI) Monograph
(Number 13) found that smokers compensate for the lower
yield of Lights cigarettes by smoking more intensely, more
often, or by fully or partially covering the ventilation holes to
obtain a desired level of nicotine, thus negating any predictive
value of Lights categories regarding disease risk.6 NCI also
found that the manufacturers intentionally used Lights descrip-
tors to market cigarettes as safer, and many smokers believed
this message and switched in lieu of quitting.7 In the FSPTCA
preamble, Congress stressed the public health signiﬁcance of the
Lights deception noting, ‘‘mistaken beliefs about the health con-
sequences of smoking ‘low tar’ and ‘light’ cigarettes can reduce
the motivation to quit smoking entirely and thereby lead to
disease and death.”2
Tobacco manufacturers responded to the ban by removing the
terms explicitly listed in the law and substituting colour brand
name descriptors that exactly corresponded to the banned Light
descriptors. At the same time, they were appealing to the
federal court, arguing that passage of the FSPTCA eliminated
any reasonable likelihood that they would commit future RICO
violations.8 However, following actions similar to the FSPTCA
in other nations, manufacturers responded by using colour sub-
stitutes on packages as well as alternative terms.9–13 Subsequent
studies found that consumers perceive colour descriptors on
packaging as they do Lights descriptors, as less harmful to
smoke than regular brands,14–18 and thus the colour descriptors
are apt to perpetuate the Lights deception. The purpose of the
present study is not to further examine consumer perceptions of
risk associated with package colours and descriptors, but to
address the urgent question for the FDA: Did Section 911 end
the Lights deception as Congress intended, or has the provision
been circumvented by the manufacturers’ systematic colour-
name coding of Lights brands?
To address this question, this study examined three comple-
mentary lines of evidence: manufacturer intent reﬂected by
brand name changes and marketing materials sent by PM to its
retailers prior to the ban19 and by manufacturers’ annual reports
required by Massachusetts Department of Public Health
(MDPH) listing ﬁlter ventilation by full brand and sub-brand
name;20 consumer response to the package changes based on a
nationally representative survey of smokers conducted 1 year fol-
lowing the date of implementation; and market response based
on national sales of Lights versus regular cigarettes before and
after the ban. The combined evidence of this paper assesses
tobacco industry compliance with the ban on Lights descriptors
and regulatory actions available if the FSPTCA has been violated.
METHODS
Materials sent by PM to retailers in spring, 2010 were identiﬁed
in the Legacy Tobacco Documents Library,19 and reviewed to
determine company intent and manner of modifying Lights
brand names in response to the ban. Manufacturers’ annual
reports of nicotine yield and related features of all products
ﬁled with MDPH were analysed for the years 2009–2011 focus-
ing on the brand family with the largest market share by each of
the major manufacturers: Marlboro by PM, Camel by Reynolds
American, and Newport by Lorillard Tobacco, inclusive of 83
sub-brands for a total market share near 60%.21
A sub-brand in MDPH reports is speciﬁed as a unique com-
bination of physical design and labelling characteristics. The
numbers of sub-brands with a Lights descriptor and the
numbers of sub-brands with one of the new typically used
colour descriptors in the brand name, identiﬁed as described
above, were tabulated for the years 2009 and 2011. Changes in
these numbers were examined for the year just prior to and fol-
lowing the ban. The mean per cent ﬁlter ventilation among sub-
brands was computed and compared across Lights descriptor
categories prior to the ban and across colour descriptor categor-
ies following the ban. A paired t test was used to test for a dif-
ference between per cent ventilation of PM sub-brands with
Lights descriptors in 2009 prior to the ban and corresponding
sub-brands in 2010 following the ban, using the PM retailer
brochure which directly links new colour descriptors with the
substituted Lights descriptors.19
A public opinion survey representative of the US adult popu-
lation ages 18 years and older excluding Hawaii and Alaska was
conducted via telephone from 18 May to 5 June 2011 by Social
Science Research Solutions an independent research company,
under contract with Harvard School of Public Health. The
sample was obtained by bilingual random digit-dialling of land-
line telephones in households and of cell phone numbers, and
with random selection of a single respondent within each house-
hold. This survey oversampled smokers and a minimum of 30
interviews was conducted in Spanish for representation of the
Hispanic population. The response rate was 51%. A total of
1021 completed the smoking component of the survey until
reaching quotas of current smokers (n=510) for the present
study and non-smokers (n=511) for other unrelated research.
All data were weighted in a multi-phase design to adjust for the
probability of selection and systematic non-response bias. The
ﬁnal weighting stage involved poststratiﬁcation adjustment by
raking so that the weighted sample reﬂects the US adult popula-
tion along the lines of age-by-gender, race/ethnicity, education
and census region. The survey was exempt from Institutional
Review Board (IRB) approval. All respondents were asked about
current and prior year smoking status in addition to demograph-
ics. Current smoking status was determined in the survey on the
basis of responses to the questions, ‘Have you smoked at least
100 cigarettes in your entire life?’, and ‘Do you now smoke
cigarettes every day, some days or not at all?’ Prior smoking
status was determined on the basis of responses to the question,
‘Six months ago, were you smoking cigarettes every day, some
days, or not at all?’ Smokers were ﬁrst asked to name their usual
cigarette brand based on the Lights descriptors banned a year
before, and then asked three additional questions: ‘In the past
six months, how difﬁcult has it been for you to identify your
usual brand of cigarettes?’; ‘Has it been very easy, somewhat
easy, somewhat difﬁcult, or very difﬁcult?’; and ‘What is the
main color on the cigarette package of [your usual brand] that
you smoked most often during the past 30 days?’ Descriptive
statistics incorporating the sampling weights were computed,
and percentages and 95% CIs are reported. The proportions of
correctly identiﬁed package colours were compared across
respondent usual brand descriptor categories using contingency
table analysis and the Pearson χ2 statistic. All statistical analyses
incorporated survey weights.
Cigarette sales and market share were derived from annual and
quarterly ScanTrack scanner data licensed from ACNielsen22 for
the years 2009 and 2010. Data for 2011 were not available at the
time of the study. ScanTrack sampling is projected to represent
approximately 95% of food and drug stores, 100% of conveni-
ence stores and 40% of mass merchandisers in the USA.
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PM sub-brands marketed with a colour in the brand name in
2009 prior to the ban were identiﬁed in the MDPH data.
Sub-brands introduced with one of the new colour descriptors
in the fourth quarter of 2010 following the ban were identiﬁed
by the retailer brochure that directly links the new colour
descriptors to the substituted Lights descriptors. The total 2009
and fourth quarter 2010 market shares of these colour named
sub-brands were compared.
The total market shares of Marlboro, Camel and Newport
sub-brands with Lights terms in the brand names in the ﬁrst half
of 2010 were compared with the total market shares of the cor-
responding brands linked by Universal Product Code (UPC)
used for tracking trade items in stores in each of the last two
quarters of 2010 following the ban.
RESULTS
Brand name changes
Examination of PM’s retailer manual and analysis of the reports
to MDPH conﬁrmed that in response to the ban, the major cig-
arette manufacturers removed the terms explicitly stated in the
law and substituted new colour terms for Lights brand name
descriptors. The PM retailer manual states, ‘current pack
descriptors such as light, ultra-light and mild will be removed
from all packaging’ and new names were provided for each
brand speciﬁed. ‘Marlboro Light’ sub-brands were renamed
‘Marlboro Gold’. ‘Marlboro Mild’ sub-brands were renamed
‘Marlboro Blue’. ‘Marlboro Ultra-light’ sub-brands were
renamed ‘Marlboro Silver’.19 The same colour substitutions
occurred for Parliament, Virginia Slims, L&M and Basic sub-
brands; while R.J. Reynolds (RJR) used ‘Blue’ for ‘Camel
Lights’ sub-brands and ‘Silver’ for Ultra-light sub-brands; and
Lorillard used ‘Blue’ and ‘Gold’ for ‘Lights’ sub-brands.
The numbers of Marlboro, Camel and Newport sub-brands
with one of the colour descriptors Blue, Gold or Silver in the
name increased over 10-fold from three in 2009 to 33 in 2010
as well as 2011, while the number of sub-brands with Lights
descriptors dropped from 35 to zero in 2011 following the ban
(ﬁgure 1). These Lights sub-brands, which were subsequently
renamed with colour descriptors, represented 31.8% of the US
cigarette market in 2009.22
Filter ventilation
The mean per cent ﬁlter ventilation for Lights categories of the
major brands in year 2009, prior to the ban, were graduated
with levels that corresponded to the ventilation ranges of Lights
categories described in PM internal industry documents, listing
20%–30% ﬁlter ventilation for light and 45%–70% ﬁlter
ventilation for ‘ultra-light’ cigarettes (table 1).6 Prior to the ban,
per cent ﬁlter ventilation levels did not correspond with colour-
named descriptor categories. Filter ventilation was 13.0% for
Marlboro Blue, 31.0% for Camel Gold and 32.4% for Camel
Silver. In contrast, per cent ﬁlter ventilation did correspond
with the Blue, Gold, and Silver colour brand name descriptors
following the ban. Further, the same categories of per cent ven-
tilation levels that were previously associated with Lights
descriptors were associated with the postban colour brand name
descriptor categories (table 1).
A comparison of the per cent ﬁlter ventilation levels among
30 discrete PM sub-brands with Lights descriptors in 2009 that
were renamed with colour descriptors following the ban found
no statistical signiﬁcance (mean difference, 3.4 percentage
points; p=0.701) (table 2), indicating that per cent ventilation
of these Lights sub-brands did not change when renamed with
the new colour descriptors.
Consumer response to package changes
Current smoker respondents in the public opinion survey were
mean age 43.2 years; 46.4% female; 66.4% White, 14.5%
Black, Non-Hispanic and 10.7% Hispanic; 51.1% married or
living with a partner; 57.8% with high school or less education;
and 56.3% had ≤ $30 000 household income. Smokers identi-
ﬁed their usual brand smoked as 51% ‘full ﬂavour’, 5%
‘medium’, 31% light, 7% ‘ultralight’ and 4% ‘none of the
above’.
One year after the ban, 88%–91% of smokers found it either
‘somewhat easy’ or ‘very easy’ to identify their usual brand of
cigarettes by the banned descriptor names, Lights, Mediums or
Ultra-lights. No statistically signiﬁcant differences in the percen-
tages were found across Lights and full-ﬂavour categories,
ranging from 88% to 92% (ﬁgure 2). In all, 68% of smokers
correctly associated the substituted colour on their packages
with the banned terms, ranging from 52.4% among smokers of
ultra-lights to 79.9% among smokers of full ﬂavour/regular
cigarettes (p<0.001) (ﬁgure 3).
Market response to package changes
A total market share of 0.36% was found for the two PM sub-
brands that used colour brand name descriptors in 2009 and
30.3% market share for PM sub-brands that used one of the brand
name colour descriptors in 2010, for a nearly a 100-fold increase.
The total market share of the sub-brands with Light descriptors
among Marlboro, Camel and Newport brands in the ﬁrst two
Figure 1 Numbers of sub-brands named by Lights and colour
descriptors.
Table 1 Mean per cent filter ventilation corresponding to ‘Lights’
and colour-named descriptor categories among major brands
Category
Mean per cent filter ventilation
Marlboro Camel Newport
Year: 2009
Light 29% 32% 23%
Ultra-light 46% 56% −
Year: 2010
Blue − 29% 28%
Gold 29% 38% 34%
Silver 50% 40% −
Year: 2011
Blue − 34% 32%
Gold 28% 40% 36%
Silver 47% 42% −
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quarters of 2010 (34% and 33%) was similar to that of sub-brands
matched by UPCs in each of the second two quarters of 2010
(31% and 30%), showing no marked decline in annual sales.
DISCUSSION
Tobacco manufacturers appear to have circumvented the ban on
Lights descriptors by intentionally substituting colour brand
name descriptors, while maintaining the same gradient of venti-
lation used for Lights designations in the new colour-coding
scheme. The present ﬁndings appear to support the FDA’s pos-
ition in a letter to PM regarding the use of a Marlboro Lights
package onsert prior to the ban.23 The onsert advised consu-
mers regarding the pack changes and substitution of colour
name descriptors as listed in the retailer manual. The FDA
stated that the onsert suggests that Marlboro in the gold pack
will have the same characteristics as Marlboro Lights, including
any mistaken attributes associated with light cigarettes and may
perpetuate the mistaken beliefs associated with these
cigarettes.24
The population survey found that 1 year following the ban
smokers still perceived their usual brands as Lights or full
ﬂavour. While smokers of full ﬂavour cigarettes were more
often correct than smokers of Lights category brands in identify-
ing their usual brand’s pack colour, the majority of smokers of
brands in all categories correctly identiﬁed their brands’ pack
colour. The NCI Monograph ﬁndings suggest that when
smokers no longer perceive certain brands as Lights, fewer
youth will initiate to low yield cigarettes and less switching
from ‘full ﬂavour’ to light cigarettes will occur.7 Consequently, a
relative decrease in the sales of low yield cigarettes should be
expected. However, national cigarette sales for Lights cigarettes
did not change after the ban, suggesting the perpetuation of
mistaken beliefs associated with these brands.
A review of industry practices following similar bans in other
countries concluded that nations should ban Lights descriptors
Table 2 Comparison of ventilation in Philip Morris cigarette brands with colour names and the Lights brands replaced
Sub-brand Colour name substitute Per cent ventilation 2009 Per cent ventilation 2010 Δ Per cent ventilation
Basic lights 100s box Gold 23 16 7
Basic lights 100s soft pack Gold 23 16 7
Basic lights box Gold 17 15 2
Basic lights soft pack Gold 16 15 1
Basic menthol lights 100s box Gold 20 23 3
Basic menthol lights 100s soft pack Gold 19 25 6
Basic menthol lights box Gold 16 17 1
Basic menthol lights soft pack Gold 12 14 2
Basic menthol ultra-lights 100s box Blue 49 45 4
Basic menthol ultra-lights box Blue 42 39 3
Basic ultra-lights 100s box Blue 47 52 5
Basic ultra-lights 100s soft pack Blue 50 48 2
Basic ultra-lights box Blue 41 42 1
Basic ultra-lights soft pack Blue 43 46 3
Marlboro lights 100s box Gold 30 24 6
Marlboro lights 100s soft pack Gold 30 24 6
Marlboro lights 25s box Gold 18 25 7
Marlboro lights box Gold 25 23 2
Marlboro lights soft pack Gold 24 23 1
Marlboro medium 100s box Red label 20 23 3
Marlboro medium 100s soft pack Red label 25 21 4
Marlboro medium box Red label 18 17 1
Marlboro medium soft pack Red label 22 23 1
Marlboro ultra-lights 100s box Silver 49 52 3
Marlboro ultra-lights box Silver 43 53 10
Merit lights 100s soft pack Gold 33 32 1
Parliament lights 100s soft pack White 30 34 4
Parliament lights box White 30 35 5
Parliament menthol lights box White 22 23 1
Virginia slims luxury lights 120s box Gold 27 28 1
Mean absolute difference in per cent ventilation 3.4
Sources: Philip Morris, USA7 and Annual Reports to Massachusetts Department of Public Health.18
Figure 2 Percent of smokers reporting “somewhat easy” or “very
easy” to identify their usual cigarettes by the banned descriptor names.
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and ‘misleading numbers, the use of colours, imagery, brand
extensions, and other devices that contribute to deception’.24
The FDA appears to have the authority to do this based on the
FSPTCA in order to end the deception of reduced risk asso-
ciated with cigarette descriptor terms. The FDA’s Draft
Guidance in September 2011 states if ‘the name of the cigarette
brand was modiﬁed or changed, the cigarette is a new tobacco
product and… the manufacturer must follow an appropriate
regulatory pathway to market (i.e., a substantial equivalence
report under 905( j), or a premarket [new] tobacco application
under 910(b)).’25 Substantial equivalence pertains to products
marketed after 15 February 2007 and requires that the product
has the same characteristics as a predicate product on the
market as of that date or that the manufacturer demonstrate to
the FDA that it does not raise different questions of public
health. Similar to the language of substantial equivalence guid-
ance for the FDA regulated medical devices, ‘different questions’
may be raised by changes in the product only and not necessar-
ily by the product’s negative effects.26 Different questions of
public health are strongly suggested by: (a) manufacturers’ sub-
stitution of new colour brand name descriptors for Lights, while
maintaining the gradient of per cent ventilation levels associated
with the brand name descriptors and (b) consumers’ continued
identiﬁcation and smoking of these brands on the basis of the
colour name descriptors.
Section 902 (‘Adulterated Tobacco Products’) allows the FDA
to require removal of the modiﬁed brands and varieties from
the market.2 Without a ﬁnding of substantial equivalence, the
law requires manufacturers to submit premarket new tobacco
product applications for the FDA approval prior to marketing
modiﬁed brands.25 Manufacturers could remove all packaging
changes not required by Section 911 and conduct testing to
demonstrate to the FDA that the new products are appropriate
for the protection of the public health and that the proposed
packaging, labelling and design do not create false or misleading
perceptions of safety.2
Other tobacco product characteristics in addition to labelling
may contribute to false perceptions regarding risk, including
concentrations of smoke constituents attributable to ﬁlter venti-
lation, and chemosensory effects. Colour-coded brand name
descriptors associated with the ventilation of Lights appear to
perpetuate the deception. Whether these descriptors maintain
the false perception that such brands are ‘safer’ than others is
not addressed in this study. Previous ﬁndings suggest that consu-
mers do perceive brands with colours used as descriptors on
packaging as being less harmful to smoke than regular
brands.14–18 The present study is exploratory but does highlight
the need for manufacturers to apply for premarket approval of
these brands as new products in which they produce evidence
that the FDA can evaluate and determine whether sales of these
products are in the public health interest.
This study has limitations. Marketing materials of only one of
the three major manufacturers were available for examination,
the company with the largest market share. Annual reports of
all manufacturers were available for examination, and coverage
included all cigarette sub-brands whose brand families
accounted for at least 3% of market in respective years as
required by the Massachusetts regulation. The public opinion
survey did not ascertain whether respondents had their cigarette
pack in hand when querying about its colour, which might have
led to overestimation of their ability to identify pack colour.
Smoking status of respondents was not veriﬁed with biomarkers,
and their reported usual brand was not veriﬁed independently.
ACNielsen ScanTrack data are comprehensive with respect to
the food, drug and convenience store channels, but less so for
mass merchandisers, although we are unaware of signiﬁcant dif-
ferences in market share in mass merchandisers that would
account for the present ﬁndings. Finally, the postban market
data in the last quarter of 2010 had not yet incorporated the
new colour-named brand descriptors; nevertheless, comparisons
made on the basis of UPC codes are believed to be reliable.
The ﬁndings of the present research strongly suggest that
tobacco manufacturers have evaded one of the most important
provisions of the FSPTCA for protecting the public health from
the leading cause of preventable death and disease. The federal
court has ordered tobacco companies to publicly admit that they
have lied about the dangers of smoking in the past.27–29 Yet, far
more important to the public health would be to ensure that the
industry does not misuse Section 905( j) regarding substantial
equivalence or other key provisions of the law or the FDA regu-
latory process to perpetuate public deception into the future.
What this paper adds
▸ By substituting colour brand name descriptors for banned
Lights descriptors, tobacco manufacturers appear to have
circumvented the FDA ban on misleading descriptors that
convey messages of reduced health risk, a critical provision
of the FSPTCA for protecting the public health from the
leading cause of preventable death and disease.
▸ Ninety percent of smokers are still able to recognize their
usual brand as “light“ one year after the ban.
▸ The FPSTCA provides appropriate regulatory mechanisms to
address the tobacco industry’s perpetuation of the public
deception concerning Lights cigarettes, including banning
products that have evaded the law as adulterated (Section
902) and ensuring that the industry does not misuse Section
905( j) regarding substantial equivalence or other key
provisions or FDA regulatory processes.
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